You are hereArticles

Articles


UPDATED REVIEW: VALIDATION AND METHOD VALIDATION PARAMETERS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Paras Virani1, 2*, Parul Jain3, Hasumati Raj2, Vineet Jain2
1Research Scholar 2014, Gujrat Technological University, Gujarat
2Department of Quality assurance, Shree Dhanvantary Pharmacy College, Kim, Surat, Gujarat
3Department of Quality assurance, Maliba Pharmacy College, Bardoli, Surat, Gujarat
parasvirani@gmail.com

ABSTRACT
Validation is an act of proving that any procedure, process, equipment, material, activity  or system performs as expected under given set of conditions and also give the required accuracy, precision, sensitivity, ruggedness. Validation parameter is used for establishing documented evidence which proves that performance characteristics of the method meet the requirements for the intended analytical applications. The goal of validation is to demonstrate that analytical results produced by the application of a particular method are fit for an intended purpose. In this review article we discussed about the validation and its important parameter.


PRODUCT QUALITY COMPLAINT MANAGEMENT IN PHARMACEUTICAL INDUSTRY – AN OVERVIEW

{ DOWNLOAD AS PDF }

ABOUT AUTHOR:
Himani Devliyal
Department of Pharmacology,
Delhi Institute of Pharmaceutical Sciences and Research
Delhi University, New Delhi
himanidevliyal@gmail.com

ABSTRACT
This article covers fundamental basics of product quality complaint. We would learn what product quality is all about, how the product quality complaints are made, processed, investigated and changes implemented. Also we would go through the basics of case processing, how the complaints are classified, categorized based on the priority and then investigated. We would also go through the formal process of responding to the customer and increasing their faith in the company.
A PQP (product quality problem) can be defined as an issue arising due to change in color, odor, appearance, quality, safety and effectiveness of a product. A PQP is a grave concern and is directly related to the efficacy and safety of a drug.


CASE REPORT ON OGILVIE’S SYNDROME: A RARE CLINICAL ENTITY

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Jyothi.P, A.Sireesha, D.Venugopal*, J.Jyothi
Department of Pharmacy Practice, P. RamiReddy Memorial College of Pharmacy,
Kadapa, Andhra Pradesh, India.
venugopal.pharmd@gmail.com

ABSTRACT
This is a syndrome of acute intestinal pseudo-obstruction associated with massive dilation, usually of the colon, but also of the small intestine. It describes the phenomenon of an acute colonic pseudo-obstruction without a mechanical cause. Mechanical obstruction is absent and there is parasympathetic nerve dysfunction. It was first described by Sir William Ogilvie in 1948, an English surgeon who was also an examiner for Oxbridge and wrote papers on fractures and hernias. It is a relatively rare condition. Males are more commonly affected than females. It is more common in the elderly. An imbalance in the autonomic innervations (sympathetic over activity and parasympathetic suppression) has been thought to be the pathophysiological factor in the causation of this condition. Reported here is a case of acute colonic pseudo-obstruction which developed in a female patient of age 45 with hypertension and histerectomy was made 25 years back and was treated conservatively. The patient stool culture should be done periodically and if any infectious agents were found should be monitored and appropriate treatment has to be done. It usually responds to non-operative therapy, but occasionally requires surgical intervention.


A SHORT REVIEW ON ANTI-DIABETIC AGENT

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Deepika Gautam1*, Deepti Gautam2
1Department of Chemistry, Lucknow University,
Lucknow, Uttar Pradesh, India
2Department of Nursing, Era’s Lucknow Medical college and Hospital,
Lucknow, Uttar Pradesh, India
*yashdeepika1@gmail.com

ABSTRACT
Different type of natural and synthetic agents for the treatment of Type 2 diabetes mellitus improve the metabolic profile but do not reestablished normality. They also reduce chronic diabetic complications, but they do not remove completely them. Thus, for the treatment of type2 diabetes mellitus new agents with novel actions are required to complement and extend the capabilities of existing treatments. Insulin resistance and beta-cell failure, which are main cause in the pathogenesis of Type 2 diabetes, in this review we discussed about some natural and synthetic molecule and their targets and some old oral ant diabetic drug and their mode of action.


DIABETIC FOOT ULCER: A SERIOUS PROBLEM FOR DIABETIC PATIENT

{ DOWNLOAD AS PDF }

ABOUT AUTHOR:
Amitava Sinha Ray
RANBAXY LABORATORIES LTD.
West Bengal, India
a.amitava.s@gmail.com

ABSTRACT:
Diabetes is a major problem across the world also it is a serious problem in India. Diabetes Mellitus is a silent killer of human body. Several types of complication are occurred in diabetic patient. One of the serious complications is Diabetic foot ulcer. Generally occurred due to breakdown in the skinand subcutaneous tissue also muscle. It will be more dangerous if it will become infected. Sometimes it is also needed to cut down the leg by surgery to prevent the spread of infection. A diabetic patient should take care for his foot to avoid this type of complication, also should be more care full to the management of blood sugar in normal level.


LOCAL ANAESTHESIA (LA): AN OVERVIEW

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Mayure Vijay Kumar*, V. Sravanthi
Maheshwara College of Pharmacy (B-Pharm Scholar)
Department of pharmacology,
Maheshwara College of Pharmacy, Chitkul (V), Isnapur “X” Road, Patancheru, Hyderabad, A.P.
mayurevijaykumar@gmail.com

ABSTRACT:
The anaesthetic agents are the drugs which causes anaesthesia-reversible loss sensation. It deals with the property of relieving the pain without eliminating sensation. These drugs are generally administered to facilitate surgery. It can be described by two main classes. General anaesthetic, which causes a reversible loss of consciousness, and local anaesthetics, which causes a reversible loss of sensation for a limited region of the body while maintaining consciousness. Here I explain about the Local anaesthetics agents that prevent transmission of nerve impulses without causing unconsciousness. They act by binding to fast sodium channels from within in an open state.
BACKGROUND: The purpose of this Review article is to summarize the Local anaesthetics agents, general mechanism, structures, therapeutic uses, adverse effects and also explains their properties.


FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES: ISONIAZID

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Umatiya Imran*, Chintan Aundhia, A.K.Seth, Sachin Chauhan, Nirmal Shah
Department of pharmacy, Sumandeep Vidhyapeeth University,
Piparia, Waghodia, Vadodara, Gujarat, India
imran_umatiya@yahoo.com

ABSTRACT
Tuberculosis is an infectious disease caused by Mycobacterium Tuberculosis which attacks lungs and other parts of the body. Isoniazid is a hydrophilic drug that is having a first line antituberculosis drug. Entrapment Efficiency has been improved by preparing Solid Lipid Nanoparticles (SLNs). Two different variable Stearic acid and Tween 80 were used by using w/o/w double emulsion-solvent evaporation method by using 32 factorial designs. Particle size, Surface Morphology, Entrapment efficiency and In-vitro diffusion studies were evaluated for prepared SLNs. Different combination of Surfactant and Lipid were found to have significant effect on entrapment efficiency but not on drug release. The prepared SLNs were found in spherical shape and 678 nm particle size was found. % Entrapment efficiency were found from 31.90±0.41 to 74.89±0.67. Present Work is focused on increase incorporation of drug into SLN. Work indicates that formulation of SLNs loaded INH can give reliable therapeutic effect for the treatment of tuberculosis by prolonged action.


RESEALED ERYTHROCYTES AS A POTENTIAL DRUG CARRIER: A REVIEW

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Tapan Behl*, Ishneet Kaur, Rashi Wanchoo Misri, Heena Goel
Senior Research Fellow, Department of Pharmacology,
Vallbhbhai Patel Chest Institute, University of Delhi, Delhi.
tapanbehl31@gmail.com

ABSTRACT
Drug delivery and drug targeting systems developed by various researchers are beleaguered to deliver the drug safely to the target sites without much interaction with other tissues of the body, so as to increase its bioavailability and reduce the adverse effects of that drug. In this approach, many drug carriers have been developed which are being widely used these days for increasing the efficacy and safety of the pharmaceutical products. Among the cellular carriers, the erythrocytes are the most potentiated drug carriers with very capitalizing properties like precise site specificity and sustained drug release. The circulation of erythrocytes into every corner of the human body is one such another advantage, thus making them useful for drugs which cannot be taken to their target site by any other carrier. Resealed erythrocytes are prepared by isolating erythrocytes from the plasma of the blood sample of an organism of interest, breakdown of cells using different methods and then entrapping the drug (which is to be administered into the body) into the erythrocytes by various techniques such as hypotonic haemolysis, hypotonic dilution, hypotonic pre-swelling method, dialysis method, isotonic osmocytosis, chemical perturbation of the membrane, electro-insertion method, entrapment by endocytosis, lipid fusion method etc., and then finally they are sealed back again, thus, accounting for their name – “Resealed Erythrocytes”.


FORMULATION AND EVALUATION OF FAST DISSOLVING TABLET OF SILYMARIN

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Brij Mohan*, Seema Saini, NS Gill
Department of Pharmaceutics,
Rayat Institute of Pharmacy, SBS Nagar, Punjab
rana.brijmohan@gmail.com

ABSTRACT:
In this investigation mouth dissolving tablets of Silymarin were prepared using different superdisintegrants by dry granulation method. Fast dissolving tablets were evaluated for physicochemical properties and in vitro dissolution. The preformulation studies and tablet evaluation test were performed and result were within the limit. The powder blend was evaluated for angle of repose, bulk density, tapped density, compressibility index and Hausner ratio. The powder blend show satisfactory flow properties. The silymarin tablet evaluated for tablet general appearance, hardness test, weight variation and drug content estimation. Oral route is the most preferred route for administration of various drugs because it is regarded as safest most convenient and economical route. Recently researcher develop the new dosage form fast dissolving tablet (FDT) with improve patient compliance and convenience. Fast dissolving tablets which dissolve rapidly in saliva without additional water and chewing. Fast dissolving tablets overcome the disadvantages of conventional dosage form especially dysphagia in pediatric and geriatric patients.
All the formulations shows uniform weight, hardness and friability data indicates good mechanical resistance of the tablet. All the tablets were disintegrated between min. The optimized (F6) formulation showed good disintegration time and release profile with maximum drug being released.


MEDICATION ERROR - MAJOR PROBLEM IN HEALTHCARE PRACTICE

{ DOWNLOAD AS PDF }

ABOUT AUTHOR:
Dinesh Kumar Meena
Department of Pharmacy,
Annamalai University, Annamalai nagar, Tamil Nadu.
*dinesh8989pharmd@gmail.com

ABSTRACT
A medication error is the failure of treatment process that may be harmful for the patient. A medication error can occur in deciding which medicine and dosage regimen to use, prescription writing, manufacturing the formulation, administrating the medicine, monitoring therapy. Avoiding medication error is important for the safety of patient as well as better therapeutic outcomes. Medication error may not be clinically significant on many occasions but they have serious economic consequences like extended hospital stays, additional treatment and malpractice litigation. Medication error are well known problem in hospitals. Medication error and adverse drug reactions are one of the main causes for adverse events in hospital leading to disability and death. Pharmacist is responsible for the safe and appropriate use of medication in all pharmacy practice settings. As the part of the multidisciplinary health care team, the pharmacist role is to cooperate to establish patient-specific drug therapy regimens designed to achieve predefined therapeutic outcomes without subjecting the patient to undue them. As pharmacist becomes more involved in patient – specific care, technician is asked to perform tasks that have previously been restricted to pharmacists. As their responsibilities expand, technician need to be aware of the significance and cause of medication errors and to recognize their role in preventing those errors.